"Lung adenocarcinoma cancer" trang 1 - tải miễn phí từ tailieunhanh
The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010

The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010
11    1    1
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): An open-label, non-randomized, multicenter, phase IV clinical trial

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): An open-label, non-randomized, multicenter, phase IV clinical trial
7    72    1
Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma
4    54    1
A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: A survival cohort analysis

A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: A survival cohort analysis
8    44    1
High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy

High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy
13    77    0
Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNANEAT1 expression

Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNANEAT1 expression
14    53    1
A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma

A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma
12    27    1
UBR-box containing protein, UBR5, is overexpressed in human lung adenocarcinoma and is a potential therapeutic target

UBR-box containing protein, UBR5, is overexpressed in human lung adenocarcinoma and is a potential therapeutic target
12    32    1
Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung
12    58    0
NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer

NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer
9    47    1
LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain

LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain
15    95    0
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma

Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
13    53    1
MUC1 in lung adenocarcinoma: Crosssectional genetic and serological study

MUC1 in lung adenocarcinoma: Crosssectional genetic and serological study
8    66    1
Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China

Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China
7    33    1
BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion

BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion
13    50    1
Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma

Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma
18    27    1
LncRNA MANCR positively affects the malignant progression of lung adenocarcinoma

LncRNA MANCR positively affects the malignant progression of lung adenocarcinoma
8    22    1
An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma

An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma
12    30    1
TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway

TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway
12    1    1
Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma
12    5    1